2014
DOI: 10.1007/s00210-014-1030-0
|View full text |Cite
|
Sign up to set email alerts
|

The ruthenium nitric oxide donor, [Ru(HEDTA)NO], inhibits acute nociception in mice by modulating oxidative stress, cytokine production and activating the cGMP/PKG/ATP-sensitive potassium channel signaling pathway

Abstract: Nitric oxide plays an important role in various biological processes including antinociception. The control of its local concentration is crucial for obtaining the desired effect and can be achieved with exogenous nitric oxide-carriers such as ruthenium complexes. Therefore, we evaluated the analgesic effect and mechanism of action of the ruthenium nitric oxide donor [Ru(HEDTA)NO] focusing on the role of cytokines, oxidative stress and activation of the cyclic guanosine monophosphate/protein kinase G/ATP-sensi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 11 publications
(4 citation statements)
references
References 80 publications
0
4
0
Order By: Relevance
“…Therefore, modulating oxidative stress is a conceivable approach to diminish pain and inflammation [55,56]. Curcumin presents prominent antioxidant activity and contributes to increasing GSH, catalase and SOD levels [57].…”
Section: •-mentioning
confidence: 99%
See 1 more Smart Citation
“…Therefore, modulating oxidative stress is a conceivable approach to diminish pain and inflammation [55,56]. Curcumin presents prominent antioxidant activity and contributes to increasing GSH, catalase and SOD levels [57].…”
Section: •-mentioning
confidence: 99%
“…This cycle grants the neutralization of ROS and provides an antioxidant function to HO-1 [64]. Activation of cGMP/PKG/ATP-sensitive potassium channels lead to antinociceptive state [55,65]. Co-treatment with an HO-1 inducer increased the antinociceptive effects of opioids and cannabinoids through activation of cGMP/PKG/ATP-sensitive potassium channel pathway in a model of CFAinduced pain [66].…”
Section: •-mentioning
confidence: 99%
“…Furthermore, oxidative stress causes tissue damage. In this sense, reducing oxidative stress diminishes disease severity (Del Carlo and Loeser, 2002; Ju et al, 2011; Staurengo-Ferrari et al, 2014a). To verify whether complex I would affect MSU crystals-triggered oxidative stress, 18 animals were randomly distributed in 3 groups of 6 animals.…”
Section: Resultsmentioning
confidence: 99%
“…Nitric oxide (NO) is a key molecule in pain modulation and its therapeutic effect in painful and inflammatory conditions has been demonstrated in different studies through the use of NO donors (Staurengo-Ferrari et al, 2013, 2014a). The ruthenium NO donors inhibit inflammatory pain behaviors induced by formalin and carrageenan by reducing the recruitment of neutrophils (Staurengo-Ferrari et al, 2013), cytokine production and oxidative stress in mice (Staurengo-Ferrari et al, 2014a), and activating the cGMP/PKG/ATP-sensitive potassium channel signaling pathway (Staurengo-Ferrari et al, 2013, 2014a). The nitric oxide donor cis -[Ru(bpy) 2 (SO 3 )NO](PF 6 ) has protective effect of the gastric mucosa against the damage caused by naproxen or ethanol in mice (Santana et al, 2015).…”
Section: Introductionmentioning
confidence: 99%